Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Persistent asthma | Phase 3 | United States | 01 Oct 2012 | |
Persistent asthma | Phase 3 | Bulgaria | 01 Oct 2012 | |
Persistent asthma | Phase 3 | Germany | 01 Oct 2012 | |
Persistent asthma | Phase 3 | Hungary | 01 Oct 2012 | |
Persistent asthma | Phase 3 | Poland | 01 Oct 2012 | |
Persistent asthma | Phase 3 | Romania | 01 Oct 2012 | |
Persistent asthma | Phase 3 | Ukraine | 01 Oct 2012 | |
Persistent asthma | Phase 3 | United Kingdom | 01 Oct 2012 | |
Asthma | Phase 3 | United States | 01 Oct 2011 | |
Asthma | Phase 3 | Philippines | 01 Oct 2011 |
Phase 2/3 | 197 | (Dose 1 VR506 50 mcg) | hcedvbakrs(pwrzcweave) = lawckuudnm febjbrvebl (jrrgnaqyjo, 6.85) View more | - | 21 Apr 2020 | ||
(Dose 2 VR506 250 mcg) | hcedvbakrs(pwrzcweave) = vgyvfjhxst febjbrvebl (jrrgnaqyjo, 7.38) View more | ||||||
Phase 2/3 | 374 | Placebo | dwajcdtiyu(sdnusqmfzv) = dzvztnwxyd zgnzgneqea (cofdnzjuzs, 0.36) View more | - | 21 Apr 2020 |